- Home
- Applications
- europe
- drug development
Show results for
Refine by
Drug Development Product Applications In Europe
17 applications found
DART enables near effortless inspection of tablets, powder, and liquid formulations. Qualitative and quantitative analysis are completed by using commercially available LC/MS systems from all of the major mass spectrometry vendors. Rapid reaction monitoring is facilitated with the development of our Mobile DART-Acquity QDa platform which can move from laboratory to pilot plant in minutes enabling generation of high quality information in seconds to improve your decision making process. ...
ByBruker Corporation based in Billerica, MASSACHUSETTS (USA)
Realize the value of global clinical and genomic data with us. We help reduce your risk, enhance your pipeline value and advance your enterprise data strategy by solving the barriers of data access and enabling rapid insight ...
ByBC Platforms based in Zürich, SWITZERLAND
This purification-free method aids in producing significant insights into protein behavior, proving invaluable for drug development targeting membrane ...
ByFluidic Sciences Ltd based in Hertfordshire, UNITED KINGDOM
Facilitate the construction of human skin equivalents for wound healing research, cosmetic product development or drug delivery ...
ByRegenhu based in Villaz-St-Pierre, SWITZERLAND
Premium
The pharmaceutical industry includes discovering, developing, producing, and marketing drugs to be used as medications and vaccines to treat and cure patients across the globe. The modern pharmaceutical industry began in the early 1800s and continues to grow rapidly until this day. For example, in 2018, cancer drugs made nearly 100 billion U.S. dollars of revenue ...
ByGalaxy Scientific Inc based in Nashua, NEW HAMPSHIRE (USA)
In this example, the aggregation of magnetic nanoparticles labeled with DiR is monitored in real time. Tumor microvasculature is labeled using ...
ByMauna Kea Technologies based in Paris, FRANCE
Explore interaction profiles and identify off-target binding. Most drugs in common use are small organic molecules which interact functionally with proteins, either acting as ligands for receptors, inhibiting enzymes or blocking protein interactions, etc. Their activities have generally been established by specific cellular and molecular assays to determine mode of action. While frequently well tolerated, side-effects are nevertheless commonplace and can be the result of unexpected interference with unintended ...
ByCambridge Protein Arrays Ltd. (CPAP) based in Cambridge, UNITED KINGDOM
Our 3D printers are designed to develop research into complex drug formulation and delivery challenges. ...
ByRegenhu based in Villaz-St-Pierre, SWITZERLAND
Introducing single-cell biopsy The novel non-invasive method for single-cell omics The novel method that keeps your cells alive during biopsy from single cells Single-cell omics addresses cellular heterogeneity head on by isolating and analyzing molecular components from individual cells. While many of the existing technologies rely on cell lysis — single-cell biopsy is the only non-invasive single-cell analysis method that allows researchers to take transcriptome snapshots of a ...
ByCytosurge AG based in Glattbrugg, SWITZERLAND
In the development of new drugs high throughput screening (HTS) is often used to screen large libraries of compounds for inhibitors or stimulators of various reactions. ...
ByBioThema AB based in Handen, SWEDEN
Thermal Management: Pyroid HT pyrolytic graphite thermal spreaders and thermal vias are a powerful new material solution in the battle against thermal heat in state-of-the-art electronic circuits and devices. HT material matches the heat spreading capability of CVD diamond at 1700 W/mK but at substantially better economics. ...
ByCETCO based in New York, NEW YORK (USA)
Several of the Navigo-created, ready-to-go Affilin molecules against solid tumor targets are currently developed as protein-drug conjugates (PDCs), by combining them to a half-life extending module and an engineered toxin-carrying moiety. Compared to notoriously difficult-to-produce and inhomogeneous Antibody-Drug Conjugates (ADCs), Affilin®-based PDCs have clear advantages. ...
ByNavigo Proteins GmbH based in Halle, GERMANY
The development of highly cytotoxic drugs is needed for the success of the treatment in tumor cells. ...
ByNanovex Biotechnologies based in Llanera, SPAIN
In modern healthcare, microscopic images, X-rays, CT, PET and MRI scans generate a lot of data which provides critical indicators for patient care and research. AI can help specialists manage this data. Robovision can provide or develop powerful tools to enhance the detection, classification, and quantification of lesions or ...
ByRobovision BV based in Ghent, BELGIUM
Versatile blood research tool: Hemostasis monitoring of newly emerged anticoagulants especially during cardiac surgeries poses more and more challenges to standard diagnostic instrumentations. 3T developers have made pioneering contributions in QCM-D technology for the analysis of health-related whole blood parameters (Oberfrank et al, 2016; Sinn et al, 2011; 2010; Müller et al, 2010). Now the qCell T series provides a sophisticated platform with outstanding potential to face such challenging situations due ...
By3T Analytik GmbH & Co. KG based in Neuhausen ob Eck, GERMANY
FluidFM can therefore help to illuminate fundamental questions on virulence, virus replication, or host immune response and thereby boost the development of novel antiviral drugs and vaccines. ...
ByCytosurge AG based in Glattbrugg, SWITZERLAND
The antibody drug discovery process differs from the traditional drug discovery of small molecules as it requires the development of hybridomas and the engineering of antibodies to recognize a specific target protein. The production of recombinant antibodies in cancer treatment as well as the development of neutralizing antibodies for infectious diseases, has allowed antibody discovery platforms to interrogate the immune repertoire and ...
ByNanoCellect Biomedical, Inc. based in San Diego, CALIFORNIA (USA)